Neutrophil to Lymphocyte Ratio (NLR) is a Better Tool Rather than Monocyte to High-Density Lipoprotein Ratio (MHR) and Platelet to Lymphocyte Ratio (PLR) in Central Retinal Artery Occlusions

References

• von Graefe A. Über Embolie der Arteria centralis retinae als Ursache plötzlicher Erblindung. Ophthalmol E. 1859;5:136–157.
   Google Scholar
• Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology. 1995;102:2029–2034; discussion 2034–2025. doi:https://doi.org/10.1016/s0161-6420(95)30758-0.
   Google Scholar
• Mueller AJ. European assessment group for lysis in the eye. Evaluation of minimally invasive therapies and retionale for a prespective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol. 2003;121:1377–1381. doi:https://doi.org/10.1001/archopht.121.10.1377.
   PubMedGoogle Scholar
• Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005;140:376–391. doi:https://doi.org/10.1016/j.ajo.2005.03.038.
   PubMed Web of Science ®Google Scholar
• Schmidt DP, Schulte-Monting J, Schumacher M. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. Am J Neuroradiol. 2002;23:1301–1307.
   PubMed Web of Science ®Google Scholar
• Sahin M, Sahin A, Yuksel H, Turkcu FM, Yildirim A. Mean platelet volume in patients with retinal artery occlusion. Arq Bras Oftalmol. 2016;79:12–14. doi:https://doi.org/10.5935/0004-2749.20160005.
   PubMed Web of Science ®Google Scholar
• Rumelt S, Brown GC. Update on treatment of retinal arterial occlusions. Curr Opin Ophthalmol. 2003;14:139–141. doi:https://doi.org/10.1097/00055735-200306000-00005.
   PubMedGoogle Scholar
• Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology. 2009;116:1928–1936. doi:https://doi.org/10.1016/j.ophtha.2009.03.006.
   PubMed Web of Science ®Google Scholar
• Rudkin AK, Lee AW, Chen CS. Vascular risk factors for central retinal artery occlusion. Eye (Lond). 2010;24:678–681. doi:https://doi.org/10.1038/eye.2009.142.
   PubMed Web of Science ®Google Scholar
• Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014;5:927–946.
   PubMedGoogle Scholar
• Stojakovic T, Scharnagl H, Marz W, Winkelmann BR, Boehm BO, Schmut O. Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion. Clin Chim Acta. 2007;382:77–81. doi:https://doi.org/10.1016/j.cca.2007.03.024.
   PubMed Web of Science ®Google Scholar
• Risimic D, Nikolic D, Jaksic V, et al. Evaluation of body mass index and lipid fractions levels in patients with retinal artery occlusion. Vojnosanit Pregl. 2011;68:231–234. doi:https://doi.org/10.2298/vsp1103231r.
   PubMed Web of Science ®Google Scholar
• Risimic D, Nikolic D, Simeunovic D, Jaksic V, Cekic S, Milenkovic S. Correlation of atherogenic risk factors with retinal artery occlusion in adults. Med Glas (Zenica). 2014;11:110–114.
   PubMedGoogle Scholar
• Linton M, Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes. 2003;27:35–40. doi:https://doi.org/10.1038/sj.ijo.0802498.
   PubMed Web of Science ®Google Scholar
• Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol. 2001;88:3–6. doi:https://doi.org/10.1016/S0002-9149(01)01879-3.
   Web of Science ®Google Scholar
• Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673–2678. doi:https://doi.org/10.1161/hc4601.099485.
   PubMed Web of Science ®Google Scholar
• Satirtav G, Mirza E, Oltulu R, Mirza GD, Kerimoglu H. Assessment of monocyte/HDL ratio in branch retinal vein occlusion. Ocul Immunol Inflamm. 2019;1–5. doi:https://doi.org/10.1080/09273948.2019.1569244.
   Google Scholar
• Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010;37:710–718. doi:https://doi.org/10.1111/j.1440-1681.2009.05338.x.
   PubMed Web of Science ®Google Scholar
• Mirza E, Oltulu R, Katipoğlu Z, Mirza GD, Özkağnıcı A. Monocyte/HDL ratio and lymphocyte/monocyte ratio in patients with pseudoexfoliation syndrome. Ocul Immunol Inflamm. 2018;1–5. doi:https://doi.org/10.1080/09273948.2018.1545913.
   PubMed Web of Science ®Google Scholar
• Bolayir A, Gokce SF, Cigdem B, et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol. 2018;52:150–155. doi:https://doi.org/10.1016/j.pjnns.2017.08.011.
   PubMed Web of Science ®Google Scholar
• Dursun A, Ozturk S, Yucel H, et al. Association of neutrophil/lymphocyte ratio and retinal vein occlusion. Eur J Ophthalmol. 2015;25:343–346. doi:https://doi.org/10.5301/ejo.5000570.
   PubMed Web of Science ®Google Scholar
• Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137:425–428. doi:https://doi.org/10.1016/j.jtcvs.2008.05.046.
   PubMed Web of Science ®Google Scholar
• Kuyumcu ME, Yesil Y, Ozturk ZA, et al. The evaluation of neutrophil-lymphocyte ratio in alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;34:69–74. doi:https://doi.org/10.1159/000341583.
   PubMed Web of Science ®Google Scholar
• Bhutta H, Agha R, Wong J, Tang TY, Wilson YG, Walsh SR. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg. 2011;45:227–231. doi:https://doi.org/10.1177/1538574410396590.
   PubMed Web of Science ®Google Scholar
• Akboga MK, Canpolat U, Yayla C, et al. Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology. 2016;67:89–95. doi:https://doi.org/10.1177/0003319715583186.
   PubMed Web of Science ®Google Scholar
• Canpolat U, Çetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost. 2016;22:476–482. doi:https://doi.org/10.1177/1076029615594002.
   PubMed Web of Science ®Google Scholar
• Alan S, Tuna S, Turkoglu EB. The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behcet’s syndrome. Kaohsiung J Med Sci. 2015;31:626–631. doi:https://doi.org/10.1016/j.kjms.2015.10.010.
   PubMed Web of Science ®Google Scholar
• Karatas MB, Ipek G, Onuk T, et al. Assessment of prognostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with pulmonary embolism. Acta Cardiol Sin. 2016;32:313–320. doi:https://doi.org/10.6515/ACS20151013A.
   PubMed Web of Science ®Google Scholar
• Tamhane UU, Aneja S, Montgomery D, Rogers E-K, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653–657. doi:https://doi.org/10.1016/j.amjcard.2008.05.006.
   PubMed Web of Science ®Google Scholar
• Shen XH, Chen Q, Shi Y, Li HW. Association of neutrophil/lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Chin Med J (Engl). 2010;123:3438–3443. doi:https://doi.org/10.3760/cma.j.issn.0366-6999.2010.23.012.
   PubMed Web of Science ®Google Scholar
• Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J. 2007;154:995–1002. doi:https://doi.org/10.1016/j.ahj.2007.06.043.
   PubMed Web of Science ®Google Scholar
• Elodie L, Kimberly M, Simon FDM. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost. 2019;45:086–093. doi:https://doi.org/10.1055/s-0038-1677040.
   PubMed Web of Science ®Google Scholar
• Kumral ET, Yenerel NM, Ercalik NY, Imamoglu S, Vural ET. Neutrophil/lymphocyte ratio and mean platelet volume in branch retinal vein occlusion. Saudi J Ophthalmol. 2016;30:105–108. doi:https://doi.org/10.1016/j.sjopt.2016.02.003.
   PubMed Web of Science ®Google Scholar
• Zhu D-D, Liu X. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in branch retinal vein occlusion. J Ophthalmol. 2019;2019:0–5. doi:https://doi.org/10.1155/2019/6043612.
   Web of Science ®Google Scholar
• Favari E, Thomas MJ, Sorci-Thomas MG. High-density lipoprotein functionality as a new pharmacological target on cardiovascular disease: unifying mechanism that explains high-density lipoprotein protection toward the progression of atherosclerosis. J Cardiovasc Pharmacol. 2018;71:325–331. doi:https://doi.org/10.1097/FJC.0000000000000573.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang X, Yu B, et al. Cyclodextrin ameliorates the progression of atherosclerosis via increasing high-density lipoprotein cholesterol plasma levels and anti-inflammatory effects in rabbits. J Cardiovasc Pharmacol. 2019;73:334–342. doi:https://doi.org/10.1097/FJC.0000000000000660.
   PubMed Web of Science ®Google Scholar
• Shaw JA, Bobik A, Murphy A, et al. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res. 2008;103:1084–1091. doi:https://doi.org/10.1161/CIRCRESAHA.108.182063.
   PubMed Web of Science ®Google Scholar
• Kramer M, Goldenberg-Cohen N, Axer-Siegel R, et al. Inflammatory reaction in acute retinal artery occlusion: cytokine levels in aqueous humor and serum. Ocul Immunol Inflamm. 2005;13:305–310. doi:https://doi.org/10.1080/09273940590950990.
   PubMed Web of Science ®Google Scholar